Detection of Burkholderia pseudomallei O-antigen serotypes in near-neighbor species

BMC Microbiology

Volumn 12, Issue , 2012, Pages

  Stone, Joshua K ^a   Mayo, Mark ^b   Grasso, Stephanie A ^a   Ginther, Jennifer L ^a   Warrington, Stephanie D ^a   Allender, Christopher J ^a   Doyle, Adina ^a   Georgia, Shalamar ^a   Kaestli, Mirjam ^b   Broomall, Stacey M ^c   Karavis, Mark A ^c   Insalaco, Joseph M ^c   Hubbard, Kyle S ^c   McNew, Lauren A ^c   Gibbons, Henry S ^c   Currie, Bart J ^b   Keim, Paul ^a   Tuanyok, Apichai ^a  

^a NORTHERN ARIZONA UNIVERSITY   (United States)

^b MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^c EDGEWOOD CHEMICAL BIOLOGICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

O ANTIGEN;

ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BURKHOLDERIA; BURKHOLDERIA CEPACIA; BURKHOLDERIA MULTIVORANS; BURKHOLDERIA OKLAHOMENSIS; BURKHOLDERIA PSEUDOMALLEI; BURKHOLDERIA THAILANDENSIS; BURKHOLDERIA UBONENSIS; BURKHOLDERIA VIETNAMIENSIS; CROSS REACTION; GENE SYNTHESIS; IMMUNOBLOTTING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; SEROTYPE;

ANIMALS; BIOSYNTHETIC PATHWAYS; BURKHOLDERIA; CROSS REACTIONS; DNA, BACTERIAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENES, BACTERIAL; HUMANS; IMMUNOBLOTTING; MICE; MOLECULAR SEQUENCE DATA; O ANTIGENS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SEROTYPING;

BURKHOLDERIA; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; BURKHOLDERIA SP.; BURKHOLDERIA THAILANDENSIS; BURKHOLDERIA UBONENSIS; MUS;

EID: 84868239952     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-12-250     Document Type: Article

References (33)

1. Lipopolysaccharide endotoxins. Raetz CRH, Whitfield C, Annu Rev Biochem 2002 71 635 700 10.1146/annurev.biochem.71.110601.135414 12045108
2. Structure of bacterial lipopolysaccharides. Caroff M, Karibian D, Carbohydr Res 2003 338 23 2431 2447 10.1016/j.carres.2003.07.010 14670707
3. Invited review: bacterial lipopolysaccharides and innate immunity. Alexander C, Rietschel ET, J Endotoxin Res 2001 7 3 167 202 11581570
4. Structural and biological diversity of lipopolysaccharides from Burkholderia pseudomallei and Burkholderia thailandensis. Novem V, Shui G, Wang D, Bendt AK, Sim SH, Liu Y, Thong TW, Sivalingam SP, Ooi EE, Wenk MR, et al. Clin Vaccine Immunol 2009 16 10 1420 1428 10.1128/CVI.00472-08 19692625
5. Melioidosis: epidemiology, pathophysiology, and management. Cheng AC, Currie BJ, Clin Microbiol Rev 2005 18 2 383 416 10.1128/CMR.18.2.383-416.2005 15831829
6. Public health assessment of potential biological terrorism agents. Rotz LD, Khan AS, Lillibridge SR, Ostroff SM, Hughes JM, Emerg Infect Dis 2002 8 2 225 230 10.3201/eid0802.010164 11897082
7. Structural and immunological characterization of Burkholderia pseudomallei O-polysaccharide-flagellin protein conjugates. Brett P, Woods D, Infect Immun 1996 64 7 2824 2828 8698517
8. Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins. Jones SM, Ellis JF, Russell P, Griffin KF, Oyston PCF, J Med Microbiol 2002 51 12 1055 1062 12466403
9. Evaluation of lipopolysaccharide and capsular polysaccharide as subunit vaccines against experimental melioidosis. Nelson M, Prior JL, Lever MS, Jones HE, Atkins TP, Titball RW, J Med Microbiol 2004 53 12 1177 1182 10.1099/jmm.0.45766-0 15585494
10. Lipopolysaccharide from Burkholderia thailandensis E264 provides protection in a murine model of melioidosis. Ngugi SA, Ventura VV, Qazi O, Harding SV, Kitto GB, Estes DM, Dell A, Titball RW, Atkins TP, Brown KA, et al. Vaccine 2010 28 47 7551 7555 10.1016/j.vaccine.2010.08.058 20837078
11. The genetic and molecular basis of O-antigenic diversity in Burkholderia pseudomallei lipopolysaccharide. Tuanyok A, Stone JK, Mayo M, Kaestli M, Gruendike J, Georgia S, Warrington S, Mullins T, Allender CJ, Wagner DM, et al. PLoS Negl Trop Dis 2012 6 1 1453 10.1371/journal.pntd.0001453 22235357
12. Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species. Brett PJ, DeShazer D, Woods DE, Int J Syst Bacteriol 1998 48 1 317 320 10.1099/00207713-48-1-317 9542103
13. Molecular and physical characterization of Burkholderia mallei O Antigens. Burtnick MN, Brett PJ, Woods DE, J Bacteriol 2002 184 3 849 852 10.1128/JB.184.3.849-852.2002 11790757
14. Burkholderia thailandensis oacA mutants facilitate the expression of Burkholderia mallei-Like O Polysaccharides. Brett PJ, Burtnick MN, Heiss C, Azadi P, DeShazer D, Woods DE, Gherardini FC, Infect Immun 2011 79 2 961 969 10.1128/IAI.01023-10 21115721
15. Structure of the polysaccharide chains of Pseudomonas pseudomallei lipopolysaccharides. Knirel YA, Paramonov NA, Shashkov AS, Kochetkov NK, Yarullin RG, Farber SM, Efremenko VI, Carbohydr Res 1992 233 185 193 1280183
16. Structural characterization of the lipopolysaccharide O antigens of Burkholderia pseudomallei. Perry M, MacLean L, Schollaardt T, Bryan L, Ho M, Infect Immun 1995 63 9 3348 3352 7543882
17. Recovery of a Burkholderia thailandensis-like isolate from an Australian water source. Gee JE, Glass MB, Novak RT, Gal D, Mayo MJ, Steigerwalt AG, Wilkins PP, Currie BJ, BMC Microbiol 2008 8 54 10.1186/1471-2180-8-54 18384685
18. Multilocus sequence typing and evolutionary relationships among the causative agents of melioidosis and glanders, Burkholderia pseudomallei and Burkholderia mallei. Godoy D, Randle G, Simpson AJ, Aanensen DM, Pitt TL, Kinoshita R, Spratt BG, J Clin Microbiol 2003 41 5 2068 2079 10.1128/JCM.41.5.2068-2079.2003 12734250
19. Burkholderia oklahomensis sp. nov., a Burkholderia pseudomallei-like species formerly known as the Oklahoma strain of Pseudomonas pseudomallei. Glass MB, Steigerwalt AG, Jordan JG, Wilkins PP, Gee JE, Int J Syst Evol Microbiol 2006 56 9 2171 2176 10.1099/ijs.0.63991-0 16957116
20. Burkholderia thailandensis E125 harbors a temperate bacteriophage specific for Burkholderia mallei. Woods DE, Jeddeloh JA, Fritz DL, DeShazer D, J Bacteriol 2002 184 14 4003 4017 10.1128/JB.184.14.4003-4017.2002 12081973
21. Genomic islands from five strains of Burkholderia pseudomallei. Tuanyok A, Leadem BR, Auerbach RK, Beckstrom-Sternberg SM, Beckstrom-Sternberg JS, Mayo M, Wuthiekanun V, Brettin TS, Nierman WC, Peacock SJ, et al. BMC Genomics 2008 9 566 10.1186/1471-2164-9-566 19038032
22. The wbiA locus is required for the 2-O-acetylation of lipopolysaccharides expressed by Burkholderia pseudomallei and Burkholderia thailandensis. Brett PJ, Burtnick MN, Woods DE, FEMS Microbiol Lett 2003 218 2 323 328 10.1111/j.1574-6968.2003.tb11536.x 12586411
23. The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence. DeShazer D, Brett PJ, Woods DE, Mol Microbiol 1998 30 5 1081 1100 10.1046/j.1365-2958.1998.01139.x 9988483
24. Expanded Range of Burkholderia Species in Australia. Levy A, Merritt AJ, Aravena-Roman M, Hodge MM, Inglis TJJ, AmJTrop Med Hyg 2008 78 4 599 604
25. Antibiosis of Burkholderia ubonensis against Burkholderia pseudomallei, the causative agent for melioidosis. Marshall K, Shakya S, Greenhill AR, Padilla G, Baker A, Warner JM, Southeast Asian J Trop Med Public Health 2010 41 4 904 912 21073065
26. Genomic acquisition of a capsular polysaccharide virulence cluster by non-pathogenic Burkholderia isolates. Sim BMQ, Chantratita N, Ooi WF, Nandi T, Tewhey R, Wuthiekanun V, Thaipadungpanit J, Tumapa S, Ariyaratne P, Sung W-K, et al. Genome Biol 2010 11 8 89 10.1186/gb-2010-11-8-r89 20799932
27. Serology and carriage of pseudomonas pseudomallei: a prospective study in 1000 hospitalized children in Northeast Thailand. Kanaphun P, Thirawattanasuk N, Suputtamongkol Y, Naigowit P, Dance DAB, Smith MD, White NJ, J Infect Dis 1993 167 1 230 233 10.1093/infdis/167.1.230 7678106
28. Arabinose assimilation defines a nonvirulent biotype of Burkholderia pseudomallei. Smith M, Angus B, Wuthiekanun V, White N, Infect Immun 1997 65 10 4319 4321 9317042
29. Clinical features that affect indirect-hemagglutination-assay responses to Burkholderia pseudomallei. Harris PNA, Ketheesan N, Owens L, Norton RE, Clin Vaccine Immunol 2009 16 6 924 930 10.1128/CVI.00026-09 19403784
30. The prevalence of human melioidosis in Northern Queensland. Ashdown LR, Guard RW, AmJTrop Med Hyg 1984 33 3 474 478
31. Seropositivity to Burkholderia pseudomallei does not reflect the development of cell-mediated immunity. Lazzaroni SM, Barnes JL, Williams NL, Govan BL, Norton RE, LaBrooy JT, Ketheesan N, Trans R Soc Trop Med Hyg 2008 102 Supplement 1 66 S70 19121692
32. Toxin A-deficient mutants of Pseudomonas aeruginosa PA103: isolation and characterization. Ohman DE, Sadoff JC, Iglewski BH, Infect Immun 1980 28 3 899 908 6772570
33. ACT: the artemis comparison tool. Carver TJ, Rutherford KM, Berriman M, Rajandream MA, Barrell BG, Parkhill J, Bioinformatics 2005 21 16 3422 3423 10.1093/bioinformatics/bti553 15976072